Business growth

Pfizer and BioNTech coronovirus vaccines, BNT162b1 and BNT162b2, have received Fast Track status from the U.S. Food and Drug Administration. Fast Track allows to simplify development and accelerate approval of new drugs and vaccines designed to treat or prevent serious diseases.